Navigation Links
Securing the future of Europe's biological data resources
Date:5/28/2008

In a contract signed today, the European Commission has awarded 4.5 million to a pan-European consortium to decide upon the best way to unite Europes biological data resources into a sustainable, integrative bioinformatics network for the life sciences. The European Life-science Infrastructure for Biological Information (ELIXIR) project is led by the European Molecular Biology Laboratorys European Bioinformatics Institute (EMBL-EBI) and involves 32 partners from 13 countries. The consortium ultimately aims to establish a sustainably funded infrastructure for biological information in Europe, to support innovation in life science research, knowledge generation and its translation to medicine, the environment, the bio-industries and society.

Since the 1980s, the storage mechanism for biological information has gone from being an individuals notebook and published academic papers to open source databases of integrated information exchanged worldwide on a daily basis. This information and the databases that make it available to scientists around the world are an indispensable resource for modern biology. Yet commonly these resources are dependent on insecure or short term funding, meaning that the valuable data they contain and provide access to, are jeopardised when funding ends.

ELIXIR aims to protect the existing and future data held in biological data resources. The project will work to provide a European infrastructure for optimal information storage, access and integration supported by a secure funding mechanism. "Under the Framework Programme for Research, the European Commission provides support to the preparatory phase for the construction of new research infrastructures, commented Mr Robert-Jan Smits, Director of Directorate B (European Research Area: Research Programmes and Capacity) at DG Research of the European Commission. This will help catalyse the efforts and resources needed to build and ensure the sustainability of large-scale
'/>"/>

Contact: Louisa Wright
louisa@ebi.ac.uk
44-122-349-4665
European Molecular Biology Laboratory
Source:Eurekalert

Page: 1 2

Related biology news :

1. Great Plains historical stability vulnerable to future changes
2. Gene may hold key to future cancer hope
3. DOE publishes update of plan: Facilities for the Future of Science: A 20-Year Outlook
4. NASA technology helps predict and prevent future pandemic outbreaks
5. Sunbathing tree frogs future under a cloud
6. Methane from microbes: a fuel for the future
7. Setting a course for the future of tissue engineering
8. Air quality forecasts see future in space
9. Oceans Past: A Guide to Oceans Future
10. Building the future -- 21st century nano tools to repair the nervous system
11. Climate change in the Baltic Sea basin -- past, present and future

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...RONTO, November 23, 2009 - The time of day matters...o a new paper produced by a research team led by P...carborough,s vice-principal for research and colle...y at the St. George campus. , Capitalizing on ...plar tree, the research team examined how poplar t...
(Date:11/23/2009)...AMPAIGN, Ill. A new study provides "incontroverti...Toba on the island of Sumatra about 73,000 years a...les from the epicenter, researchers report. , Th...s of ash into the atmosphere, leaving a crater (no...ilometers long and 35 kilometers wide. Ash from th...
(Date:11/23/2009)...BIRMINGHAM, Ala. A new study by University of Ala...dy-mass index (BMI) and co-existing medical condit...urvival observed among African-Americans compared ...y is published online Nov. 23 in Cancer , a journ... indicates that although BMI and co-morbidity are ...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Hologic Expands Healthcare Investment in Asia 5563 1Hologic Expands Healthcare Investment in Asia 5563 2Hologic Expands Healthcare Investment in Asia 5563 3ECRI Institute Sees Upward Trend in Hospital Medical Technology Evaluation Activity 5559 1ECRI Institute Sees Upward Trend in Hospital Medical Technology Evaluation Activity 5559 2AccuVein Signs Multiple Country Distribution Agreement in Europe for Vein Illumination Device 5555 1AccuVein Signs Multiple Country Distribution Agreement in Europe for Vein Illumination Device 5555 2
...n monkeys has found that moderate exposure to alco...ivity to touch in the monkeys babies. In human chi...characteristics of the approximately 5 percent of ...Since these characteristics can lead to behavioral...reatment are important. Children who are sensitive...
...cuments malformations seen in an infant born to a ...olate mofetil (MMF), a widely used immunosuppressa...s suggest a specific birth defect pattern particul... to the fetus. The study was published in the Janu...Genetics, available online via Wiley InterScience ...
...ly known than the dangerous consequences of iron d...o cause problems. The exact origin of the genetic... (HH) has remained elusive. In a joint effort, res...atory (EMBL) and the University of Heidelberg, Ger...se. They report in the current issue of Cell Metab...
Other Biology News:Moderate prenatal exposure to alcohol and stress in monkeys can cause touch sensitivity 2Immunosuppressant further linked to birth defects 2Europe's most common genetic disease is a liver disorder 2
(Date:11/24/2009)... Ambassador to also Visit Detroit , ... David Appia, French Ambassador for International ...France Agency, , , , ,What: Ambassador Appia is a...business initiatives adopted by France to further ...pe for innovation and development., , ,When: Avail...
(Date:11/24/2009)...,Nov.24/PRNewswire/--Twomoreprestigiousuniversitie...ejobboardandcareerssiteforlifescienceprofessionals...bersofthejobboard,joining28othermajorlifesciencetr...ercenter.com ,isonlyforpost-graduatesinthelifescie...ontheInternet,BioCareerCenteristheonlyonethatserve...
(Date:11/24/2009)...d,November24/PRNewswire-FirstCall/--deCODE,genetic...ednoticefrom,theNasdaqStockMarketthattradinginthec...2009andaForm25-NSEwillbefiledwiththe,Securitiesand...ock,fromlistingonNasdaq,unlessthecompanyfilesanapp...nyhasfiledsuchanappeal,which,willstaythesuspension...
(Date:11/24/2009)... Health care employment grew by 29,000 jobs in ...w consistent growth during the U.S. recession. How...ouble, and health systems are coming closer to hav...just administrators. , (V...continued growing in October despite the shedding ...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
... Richard D. Dyer, PhD, has been,appointed Executiv...a,Therapeutics, Inc., an early stage biotechnology...pies to treat bone diseases. "We are pleased to a...o,our management team. Dr. Dyer will oversee our p...r bone diseases; he also will lead our new,initiat...
... Millennium,Pharmaceuticals, Inc. (Nasdaq: MLNM )..., M.D., Ph.D., to its Board of Directors. Dr. Leid... sciences venture capital firm,has a distinguished...,biomedical and pharmaceutical sectors. Prior to j...Chief Operating Officer of the Global,Pharmaceutic...
...egin in fourth quarter -, SEATTLE, Oct. 4 ZymoGe...together with its collaborator Merck Serono, it,ha...ministration (FDA) on a,Special Protocol Assessmen...he investigational new drug atacicept for the trea...e of two clinical studies intended to form part,of...
Other Biology Technology:Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives 2Life Sciences Leader Joins Millennium Board of Directors 2Life Sciences Leader Joins Millennium Board of Directors 3ZymoGenetics and Merck Serono Receive FDA Special Protocol Assessment for Atacicept Pivotal Study in Lupus Nephritis 2ZymoGenetics and Merck Serono Receive FDA Special Protocol Assessment for Atacicept Pivotal Study in Lupus Nephritis 3
GeneSnap from SYNGENE
DISCOVERLIGHT 6XHIS ARRAY from Pierce Biotechnology, Inc.
Mouse Anti-XAGE2 Polyclonal Antibody, Unconjugated from Abnova Corporation
...recombinant or native proteins are used to immuniz...n protocol optimized in time, quantity of antigen ...nd the use of 2 animals per protocol in order to a...n a 77-day protocol is approximately 75 mL per rab...
Biology Products: